Stage III Bladder Cancer AJCC v8

Drug Trials

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB02379	Beta-D-Glucose	1	Completed	1
DB08875	Cabozantinib	1	Active Not Recruiting	1
DB00958	Carboplatin	1	Completed	1
DB14547	Chloride ion	1	Completed	1
DB00515	Cisplatin	1	Completed	1
DB01248	Docetaxel	1	Completed	1
DB00773	Etoposide	1	Completed	1
DB06186	Ipilimumab	1	Active Not Recruiting	1
DB09035	Nivolumab	1	Active Not Recruiting	1
DB09037	Pembrolizumab	1	Completed	1
DB12257	Platinum	1	Completed	1
DB11595	Atezolizumab	1 / 2	Recruiting	1
DB11945	Avelumab	1 / 2	Recruiting	1
DB11714	Durvalumab	1 / 2	Recruiting	1
DB09035	Nivolumab	1 / 2	Recruiting	1
DB09037	Pembrolizumab	1 / 2	Active Not Recruiting	1
DB09037	Pembrolizumab	1 / 2	Recruiting	1
DB05992	Plinabulin	1 / 2	Recruiting	1
DB12887	Tazemetostat	1 / 2	Active Not Recruiting	1
DB11595	Atezolizumab	2	Active Not Recruiting	2
DB11595	Atezolizumab	2	Withdrawn	1
DB11945	Avelumab	2	Completed	1
DB14547	Chloride ion	2	Active Not Recruiting	1
DB14547	Chloride ion	2	Completed	1
DB00515	Cisplatin	2	Active Not Recruiting	1
DB00515	Cisplatin	2	Completed	1
DB11714	Durvalumab	2	Active Not Recruiting	1
DB13007	Enfortumab vedotin	2	Recruiting	1
DB12147	Erdafitinib	2	Withdrawn	1
DB08871	Eribulin	2	Active Not Recruiting	1
DB00544	Fluorouracil	2	Active Not Recruiting	1
DB00544	Fluorouracil	2	Completed	1
DB00441	Gemcitabine	2	Active Not Recruiting	1
DB11997	Interleukin-7	2	Active Not Recruiting	1
DB06186	Ipilimumab	2	Active Not Recruiting	1
DB00305	Mitomycin	2	Active Not Recruiting	1
DB00305	Mitomycin	2	Completed	1
DB09035	Nivolumab	2	Active Not Recruiting	1
DB09035	Nivolumab	2	Recruiting	1
DB09074	Olaparib	2	Recruiting	1
DB09037	Pembrolizumab	2	Completed	1
DB09037	Pembrolizumab	2	Recruiting	1
DB12257	Platinum	2	Active Not Recruiting	1
DB12257	Platinum	2	Completed	1
DB14851	Relatlimab	2	Recruiting	1
DB06273	Tocilizumab	2	Active Not Recruiting	1
DB11945	Avelumab	3	Active Not Recruiting	1
DB08875	Cabozantinib	3	Active Not Recruiting	1